(Q44612931)

4 December 2017

PPARgamma activation, by reducing oxidative stress, increases NO bioavailability in coronary arterioles of mice with Type 2 diabetes (English)

1 reference

4 December 2017

PPARγ activation, by reducing oxidative stress, increases NO bioavailability in coronary arterioles of mice with Type 2 diabetes (English)

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00718.2003

20 March 2024

1 reference

1 reference

Cardiology and cardiovascular medicine

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00718.2003

20 March 2024

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00718.2003

20 March 2024

1

Zsolt Bagi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14551045

20 March 2024

author name string

Akos Koller

2

1 reference

4 December 2017

Gabor Kaley

3

1 reference

4 December 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14551045

20 March 2024

publication date

9 October 2003

1 reference

full work available at URL

4 December 2017

https://www.physiology.org/doi/pdf/10.1152/ajpheart.00718.2003

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00718.2003

American Journal of Physiology Heart and Circulatory Physiology

20 March 2024

published in

1 reference

4 December 2017

286

1 reference

4 December 2017

H742-8

1 reference

4 December 2017

2

1 reference

Superoxide-NO interaction decreases flow- and agonist-induced dilations of coronary arterioles in Type 2 diabetes mellitus

4 December 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00718.2003

Role of oxidative stress in development of complications in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00718.2003

The effects of troglitazone, an insulin-sensitizing agent, on the endothelial function in early and late type 2 diabetes: a placebo-controlled randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00718.2003

Peroxisome proliferator-activated receptor gamma ligands increase release of nitric oxide from endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00718.2003

Endothelial dysfunction in diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00718.2003

Oxidant stress-induced increase in myogenic activation of skeletal muscle resistance arteries in obese Zucker rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00718.2003

Identification of a functional peroxisome proliferator-activated receptor response element in the rat catalase promoter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00718.2003

Oxidative stress and diabetic vascular complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00718.2003

Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00718.2003

The ligands/activators for peroxisome proliferator-activated receptor alpha (PPARalpha) and PPARgamma increase Cu2+,Zn2+-superoxide dismutase and decrease p22phox message expressions in primary endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00718.2003

Expression of peroxisome proliferator-activated receptor alpha (PPAR alpha) in primary cultures of human vascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00718.2003

Expression and function of PPARgamma in rat and human vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00718.2003

Diabetes mellitus and cardiac function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00718.2003

Metabolic and additional vascular effects of thiazolidinediones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00718.2003

Oxidative stress and cardiovascular complications in diabetes: isoprostanes as new markers on an old paradigm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00718.2003

NADH oxidoreductase is a major source of superoxide anion in bovine coronary artery endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00718.2003

New drug targets for type 2 diabetes and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00718.2003

PPAR(gamma) and glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00718.2003

Cardiac consequences of diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00718.2003

Endothelial dysfunction and pathogenesis of diabetic angiopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00718.2003

Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00718.2003

The thiazolidinedione rosiglitazone (BRL-49653) lowers blood pressure and protects against impairment of endothelial function in Zucker fatty rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00718.2003

Leukocyte lipid peroxidation, superoxide dismutase, glutathione peroxidase and serum and leukocyte vitamin C levels of patients with type II diabetes mellitus

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00718.2003

Cardiac function in perfused hearts from diabetic mice.

20 March 2024

4

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00718.2003

Troglitazone, an insulin sensitizer, increases forearm blood flow in humans

20 March 2024

10

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00718.2003

Troglitazone, a new antidiabetic agent possessing radical scavenging ability, improved decreased skin blood flow in diabetic rats

20 March 2024

11

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00718.2003

Diabetes, a New Mutation in the Mouse

20 March 2024

15

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00718.2003

Role for endothelin-1 in angiotensin II-mediated hypertension

20 March 2024

25

1 reference

https://api.crossref.org/works/10.1152/AJPHEART.00718.2003

20 March 2024

Identifiers

1 reference

4 December 2017

1 reference